Guideline for the format and content of the summary for new drug and antibiotic applications

LDR 00973nam a2200265 a 4500
001 002609431
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 930406s1987 mdu f000 0 eng d
035 ‡a(MiU)990026094310106381
035 ‡asdr-miu.990026094310106381
035 ‡a(OCoLC)15725447
035 ‡z(MiU)Aleph002609431
040 ‡aGPO ‡cGPO ‡dm/c ‡dEYM
043 ‡an-us---
074 ‡a499-K-2
086 0 ‡aHE 20.4208:An 8
245 0 0 ‡aGuideline for the format and content of the summary for new drug and antibiotic applications.
260 ‡aRockville, Md. : ‡bCenter for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, ‡c1987.
300 ‡a24 p. ; ‡c28 cm.
500 ‡a"February 1987."
500 ‡aShipping list no.: 87-243-P.
538 ‡aMode of access: Internet.
650 2 ‡aDrug Approval ‡zUnited States.
650 2 ‡aInvestigational New Drug Application ‡xmethods ‡zUnited States.
650 0 ‡aAntibiotics.
650 0 ‡aDrugs ‡zUnited States.
710 2 ‡aCenter for Drugs and Biologics (U.S.)
CID ‡a002609431
DAT 0 ‡a19930406000000.0 ‡b20210817000000.0
DAT 1 ‡a20210921140708.0 ‡b2023-10-12T17:50:06Z
CAT ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ‡aBK
HOL ‡0sdr-miu.990026094310106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015029202226 ‡sMIU ‡1990026094310106381
974 ‡bMIU ‡cMIU ‡d20231012 ‡sgoogle ‡umdp.39015029202226 ‡y1987 ‡rpd ‡qbib ‡tUS fed doc